Responses
Epidemiology
Original research
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2)
Compose a Response to This Article
Other responses
No responses have been published for this article.